Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Dev Biol ; 409(1): 95-105, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26481065

ABSTRACT

Mutations in endoglin, a TGFß/BMP coreceptor, are causal for hereditary hemorrhagic telangiectasia (HHT). Endoglin-null (Eng-/-) mouse embryos die at embryonic day (E)10.5-11.5 due to defects in angiogenesis. In part, this is due to an absence of vascular smooth muscle cell differentiation and vessel investment. Prior studies from our lab and others have shown the importance of endoglin expression in embryonic development in both endothelial cells and neural crest stem cells. These studies support the hypothesis that endoglin may play cell-autonomous roles in endothelial and vascular smooth muscle cell precursors. However, the requirement for endoglin in vascular cell precursors remains poorly defined. Our objective was to specifically delete endoglin in neural crest- and somite-derived Pax3-positive vascular precursors to understand the impact on somite progenitor cell contribution to embryonic vascular development. Pax3Cre mice were crossed with Eng+/- mice to obtain compound mutant Pax3(Cre/+);Eng+/- mice. These mice were then crossed with homozygous endoglin LoxP-mutated (Eng(LoxP/LoxP)) mice to conditionally delete the endoglin gene in specific lineages that contribute to endothelial and smooth muscle constituents of developing embryonic vessels. Pax3(Cre/+);Eng(LoxP/)(-) mice showed a variety of vascular defects at E10.5, and none of these mice survived past E12.5. Embryos analyzed at E10.5 showed malformations suggestive of misdirection of the intersomitic vessels. The dorsal aorta showed significant dilation with associated vascular smooth muscle cells exhibiting disorganization and enhanced expression of smooth muscle differentiation proteins, including smooth muscle actin. These results demonstrate a requirement for endoglin in descendants of Pax3-expressing vascular cell precursors, and thus provides new insight into the cellular basis underlying adult vascular diseases such as HHT.


Subject(s)
Blood Vessels/embryology , Blood Vessels/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Neovascularization, Physiologic , Paired Box Transcription Factors/metabolism , Actins/metabolism , Alleles , Animals , Aorta/embryology , Aorta/pathology , Embryo Loss/metabolism , Embryo Loss/pathology , Embryo, Mammalian/abnormalities , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Endoglin , Endothelial Cells/metabolism , Gene Deletion , Integrases/metabolism , Intracellular Signaling Peptides and Proteins/deficiency , Mice , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , PAX3 Transcription Factor , Phenotype , Recombination, Genetic/genetics , Somites/blood supply , Staining and Labeling
2.
Dev Dyn ; 241(6): 1034-42, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22513894

ABSTRACT

BACKGROUND: The cellular mechanisms regulating branching and growth of the intersegmental vessels (ISVs) are not well understood. We have carried out studies demonstrating that Hedgehog (Hh) signaling is a major regulator of intersomitic vessel growth. RESULTS: Inhibition of Hh activity by cyclopamine completely blocks formation of intersomitic vessels in the avian embryo. Examination of gene expression patterns in Hh-deficient embryos shows that components of the VEGF and Notch signaling pathways are down-regulated. However, we find no evidence that Notch signaling plays a significant role in regulation of intersomitic vessel growth. Indeed, it appears that Hh modulation of Vascular Endothelial Growth Factor, VEGF, is the primary regulator of growth of intersomitic vessels in the avian embryo. CONCLUSIONS: Inhibition of the VEGF pathway results in absence of ISVs, whereas stimulation of VEGF expression leads to precocious branching of ISVs. These results demonstrate that Hh is an essential modulator of VEGF expression during developmental angiogenesis.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Hedgehog Proteins/metabolism , Neovascularization, Physiologic/physiology , Signal Transduction/physiology , Somites/blood supply , Vascular Endothelial Growth Factor A/metabolism , Animals , Chick Embryo , DNA Primers/genetics , Gene Expression Profiling , Gene Expression Regulation, Developmental/genetics , Hedgehog Proteins/deficiency , In Situ Hybridization , Real-Time Polymerase Chain Reaction , Signal Transduction/genetics , Veratrum Alkaloids
3.
Hum Mol Genet ; 20(24): 4879-90, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-21926082

ABSTRACT

Fukutin and fukutin-related protein (FKRP) are involved in the glycosylation of α-dystroglycan, a key receptor for basement membrane proteins. Aberrant α-dystroglycan glycosylation leads to a broad spectrum of disorders, ranging from limb girdle muscular dystrophy to Walker-Warburg syndrome. This is the first study investigating a role of fukutin and FKRP-mediated glycosylation in angiogenesis. Transgenic zebrafish expressing enhanced green fluorescent protein in blood vessels were treated with morpholino antisense oligonucleotides that blocked the expression of fukutin, FKRP and dystroglycan. All morphant fish showed muscle damage and vascular abnormalities at day 1 post-fertilization. Intersegmental vessels of somites failed to reach the dorsal longitudinal anastomosis and in more severe phenotypes retracted further or were in some cases even completely missing. In contrast, the eye vasculature was distorted in both fukutin and FKRP morphants, but not in dystroglycan morphants or control fish. The eye size was also smaller in the fukutin and FKRP morphants when compared with dystroglycan knockdown fish and controls. In general, the fukutin morphant fish had the most severe skeletal muscle and eye phenotype. Our findings suggest that fukutin and FKRP have functions that affect ocular development in zebrafish independently of dystroglycan. Despite anecdotal reports about vascular abnormalities in patients affected by dystroglycanopathies, the clinical relevance of such lesions remains unclear and should be subject to further review and investigations.


Subject(s)
Blood Vessels/abnormalities , Blood Vessels/embryology , Glycosyltransferases/deficiency , Zebrafish Proteins/deficiency , Zebrafish/embryology , Animals , Animals, Genetically Modified , Antibodies/immunology , Blood Vessels/drug effects , Blood Vessels/pathology , Dystroglycans/metabolism , Embryo, Nonmammalian/abnormalities , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Embryo, Nonmammalian/pathology , Eye/blood supply , Eye/drug effects , Eye/pathology , Glycosyltransferases/metabolism , Models, Animal , Morpholinos/pharmacology , Phalloidine/metabolism , Proto-Oncogene Protein c-fli-1 , Somites/abnormalities , Somites/blood supply , Somites/drug effects , Somites/embryology , Staining and Labeling , Zebrafish/genetics , Zebrafish Proteins/metabolism
4.
Dev Biol ; 328(2): 363-76, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19389349

ABSTRACT

Phospholipase D (PLD) hydrolyzes phosphatidylcholine to generate phosphatidic acid and choline. Studies in cultured cells and Drosophila melanogaster have implicated PLD in the regulation of many cellular functions, including intracellular vesicle trafficking, cell proliferation and differentiation. However, the function of PLD in vertebrate development has not been explored. Here we report cloning and characterization of a zebrafish PLD1 (pld1) homolog. Like mammalian PLDs, zebrafish Pld1 contains two conservative HKD motifs. Maternally contributed pld1 transcripts are uniformly distributed in early embryo. Localized expression of pld1 is observed in the notochord during early segmentation, in the somites during later segmentation and in the liver at the larval stages. Studies in intact and cell-free preparations demonstrate evolutionary conservation of regulation. Inhibition of Pld1 expression using antisense morpholino oligonucleotides (MO) interfering with the translation or splicing of pld1 impaired intersegmental vessel (ISV) development. Incubating embryos with 1-butanol, which diverts production of phosphatidic acid to a phosphatidylalcohol, caused similar ISV defects. To determine where Pld1 is required for ISV development we performed transplantation experiments. Analyses of the mosaic Pld1 deficient embryos showed partial suppression of ISV defects in the segments containing transplanted wild-type notochord cells but not in the ones containing wild-type somitic cells. These results provide the first evidence that function of Pld1 in the developing notochord is essential for vascular development in vertebrates.


Subject(s)
Neovascularization, Physiologic/physiology , Phospholipase D/physiology , Somites/embryology , Zebrafish Proteins/physiology , Zebrafish/embryology , 1-Butanol/pharmacology , Animals , Animals, Genetically Modified , Body Patterning/physiology , Cell Differentiation/physiology , Embryo, Nonmammalian/blood supply , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/enzymology , Liver/enzymology , Neovascularization, Physiologic/drug effects , Notochord/blood supply , Notochord/drug effects , Notochord/embryology , Notochord/enzymology , Phosphatidic Acids/metabolism , Phospholipase D/genetics , Somites/blood supply , Somites/cytology , Somites/drug effects , Zebrafish/metabolism , Zebrafish Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...